+499.5%
MRNA vs CP
+19.9%
+479.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | CP | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | +0.3% | -2.6% | -2.4% |
| 7D | +5.5% | -2.7% | +8.2% | +6.8% |
| 30D | +158.7% | +0.2% | +158.6% | +160.3% |
| 3M | +182.1% | +2.6% | +179.6% | +180.5% |
| 6M | +151.8% | +6.0% | +145.8% | +145.7% |
| YTD | +393.6% | +24.9% | +368.6% | +333.6% |
| 1Y | +499.5% | +20.1% | +479.4% | +442.1% |
| All | +499.5% | +19.9% | +479.5% | +442.1% |
Cumulative growth
Daily Returns
Daily percentage return beside CP.
Daily Out/Under-Performance
Portfolio return minus CP return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CP return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded CP wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling